Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Acinetobacter, aeruginosa, African, ahead, AMR, antigen, antimicrobial, anxiety, Australia, bankrupt, baumannii, Beijing, Bharat, Biomolecular, Biopharma, Biotech, BWV, Canadian, childhood, client, clonal, copyright, counteracted, crowded, CRXT, customary, Delta, derivatization, die, died, easily, elevate, endemic, ensuing, Enterobacter, era, ESKAPE, fighting, fit, FIU, globe, greatest, herewith, ID, India, injected, Inspirevax, intramuscular, intramuscularly, intranasal, intranasally, irrespective, Japan, KBI, Klebsiella, Korea, Mutacin, mutate, nose, notably, NRC, Omicron, overuse, Petersburg, pneumoniae, pool, poverty, pre, prominent, proven, quorum, rabbit, ransom, RCE, Recce, resignation, resigned, respectfully, robust, SAA, saline, Serum, Singapore, Sinopharma, Sinovac, solicitor, spp, spurred, St, successor, surpassing, Territory, TM, trillion, Trxade, undetectable, variant, worsened, Zeneca
Removed:
accruing, agree, amino, aware, characteristic, colony, commitment, companion, concentration, consolidate, covenant, Cubist, decade, diarrhea, dictate, diligent, dramatic, entertainment, exclusively, execution, exhibited, exporting, fermenting, financially, forming, importing, inhibitory, initially, instrument, lanthionine, lifestyle, lipopeptide, measurable, methyllanthonine, MIC, necessitated, negligence, nosocomial, notified, opted, Optimer, pain, pathogenic, pattern, pharmacokinetic, physicochemical, polycyclic, possessed, preclinical, problem, profit, project, pursued, relapse, representation, resort, scarce, showed, specialty, Steering, stem, sublicensor, survival, survive, thioether, toxin, unaudited, unpaid, warranty, wholly
Filing tables
Filing exhibits
OGEN similar filings
Filing view
External links
Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
In connection with the Annual Report on Form 10-K for the period ended December 31, 2020 (the “Report”) of Oragenics, Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Alan Joslyn, hereby certify, to the best of my knowledge, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
| /s/ Michael Sullivan | |
| Name: Michael Sullivan | |
| Interim Principal Executive Officer | |
| Date: March 24, 2022 |